Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2026-01-24 @ 6:05 PM
Study NCT ID:
NCT01637402
Status:
COMPLETED
Last Update Posted:
2020-08-17
First Post:
2012-07-06
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase II Study of Increased-Dose Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer
Sponsor:
Terence Friedlander, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-03-13
Start Date Type:
ACTUAL
Primary Completion Date:
2017-02-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-02-27
Completion Date Type:
ACTUAL
First Submit Date:
2012-07-06
First Submit QC Date:
None
Study First Post Date:
2012-07-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-07-07
Results First Submit QC Date:
None
Results First Post Date:
2020-08-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-08-03
Last Update Post Date:
2020-08-17
Last Update Post Date Type:
ACTUAL